TY - JOUR
T1 - Other approaches in breast cancer screening
AU - Veron, Lucie
AU - Wehrer, Delphine
AU - Caron, Olivier
AU - Balleyguier, Corinne
AU - Delaloge, Suzette
N1 - Publisher Copyright:
© 2022 Société Française du Cancer
PY - 2022/7/1
Y1 - 2022/7/1
N2 - French breast cancer screening is based on organized screening with a mammography every two years for women between 50 and 74, and individualized screening for women at high or very high risk of breast cancer (personal history of breast cancer or atypical breast lesion or thoracic radiotherapy before the age of 25, high family risk without genetic mutation, genetic mutation). A novel approach of risk-based breast cancer screening is currently under evaluation in many countries, including France. This personalized screening, based on individual risk of having breast cancer in the next years, uses algorithms which combine clinical parameters, mammographic density, familial history and genomic (using polygenic risk score), to estimate breast cancer risk and adapt screening's frequency.
AB - French breast cancer screening is based on organized screening with a mammography every two years for women between 50 and 74, and individualized screening for women at high or very high risk of breast cancer (personal history of breast cancer or atypical breast lesion or thoracic radiotherapy before the age of 25, high family risk without genetic mutation, genetic mutation). A novel approach of risk-based breast cancer screening is currently under evaluation in many countries, including France. This personalized screening, based on individual risk of having breast cancer in the next years, uses algorithms which combine clinical parameters, mammographic density, familial history and genomic (using polygenic risk score), to estimate breast cancer risk and adapt screening's frequency.
KW - High risk of breast cancer
KW - Personalized screening
KW - Risk-based screening
UR - http://www.scopus.com/inward/record.url?scp=85129933957&partnerID=8YFLogxK
U2 - 10.1016/j.bulcan.2022.02.006
DO - 10.1016/j.bulcan.2022.02.006
M3 - Review article
C2 - 35527073
AN - SCOPUS:85129933957
SN - 0007-4551
VL - 109
SP - 786
EP - 794
JO - Bulletin du Cancer
JF - Bulletin du Cancer
IS - 7-8
ER -